Increased CD62e+ Endothelial Microparticle Levels Predict Poor Outcome in Pulmonary Hypertension Patients

Journal of Heart and Lung Transplantation

Volumn 28, Issue 10, 2009, Pages 1081-1086

  Amabile, Nicolas ^a   Heiss, Christian ^a   Chang, Vivian ^a   Angeli, Franca S ^a   Damon, Lauren ^a   Rame, Eddie J ^a   McGlothlin, Dana ^a   Grossman, William ^a   De Marco, Teresa ^a   Yeghiazarians, Yerem ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD31 ANTIGEN; CD45 ANTIGEN; ENDOTHELIN RECEPTOR ANTAGONIST; FIBRINOGEN RECEPTOR; PADGEM PROTEIN; PHOSPHODIESTERASE V INHIBITOR; PROSTAGLANDIN DERIVATIVE; VASCULAR ENDOTHELIAL CADHERIN;

ADULT; ARTICLE; BIOASSAY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL CHEMISTRY; CONTROLLED STUDY; DEATH; ENDOTHELIAL MICROPARTICLE; FEMALE; FLOW CYTOMETRY; HEART CATHETERIZATION; HEART RIGHT VENTRICLE FAILURE; HEMODYNAMICS; HOSPITAL READMISSION; HUMAN; LEUKOCYTE MICROPARTICLE; MALE; OUTCOME ASSESSMENT; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CELL-DERIVED MICROPARTICLES; COHORT STUDIES; E-SELECTIN; ENDOTHELIUM, VASCULAR; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; HYPERTENSION, PULMONARY; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 70349241954     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.06.005     Document Type: Article

References (20)

1. Farber H.W., and Loscalzo J. Pulmonary arterial hypertension. N Engl J Med 351 (2004) 1655-1665
2. Chin K.M., and Rubin L.J. Pulmonary arterial hypertension. J Am Coll Cardiol 51 (2008) 1527-1538
3. Simonneau G., Galie N., Rubin L.J., et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 43 suppl (2004) 5S-12S
4. Humbert M., Morrell N.W., Archer S.L., et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 43 suppl (2004) 13S-24S
5. Budhiraja R., Tuder R.M., and Hassoun P.M. Endothelial dysfunction in pulmonary hypertension. Circulation 109 (2004) 159-165
6. Boulanger C.M., Amabile N., and Tedgui A. Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease. Hypertension 48 (2006) 180-186
7. Morel O., Toti F., Hugel B., et al. Procoagulant microparticles disrupting the vascular homeostasis equation?. Arterioscler Thromb Vasc Biol 26 (2006) 2594-2604
8. Amabile N., Heiss C., Real W.M., et al. Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension. Am J Respir Crit Care Med 177 (2008) 1268-1275
9. Bakouboula B., Morel O., Faure A., et al. Procoagulant membrane microparticles correlate with the severity of pulmonary arterial hypertension. Am J Respir Crit Care Med 177 (2008) 536-543
10. Galie N., Torbicki A., Barst R., et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 25 (2004) 2243-2278
11. Amabile N., Guerin A.P., Leroyer A., et al. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 16 (2005) 3381-3388
12. Heiss C., Amabile N., Lee A.C., et al. Brief secondhand smoke exposure depresses endothelial progenitor cells activity and endothelial function: sustained vascular injury and blunted nitric oxide production. J Am Coll Cardiol 51 (2008) 1760-1771
13. Morel O., Ohlmann P., Epailly E., et al. Endothelial cell activation contributes to the release of procoagulant microparticles during acute cardiac allograft rejection. J Heart Lung Transplant 27 (2008) 38-45
14. Michelakis E.D., Wilkins M.R., and Rabinovitch M. Emerging concepts and translational priorities in pulmonary arterial hypertension. Circulation 118 (2008) 1486-1495
15. McLaughlin V.V., Presberg K.W., Doyle R.L., et al. Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126 suppl (2004) 78S-92S
16. Montani D., Souza R., Binkert C., et al. Endothelin-1/endothelin-3 ratio: a potential prognostic factor of pulmonary arterial hypertension. Chest 131 (2007) 101-108
17. Jimenez J.J., Jy W., Mauro L.M., et al. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res 109 (2003) 175-180
18. Abid Hussein M.N., Meesters E.W., Osmanovic N., et al. Antigenic characterization of endothelial cell-derived microparticles and their detection ex vivo. J Thromb Haemost 1 (2003) 2434-2443
19. Brogan P.A., Shah V., Brachet C., et al. Endothelial and platelet microparticles in vasculitis of the young. Arthritis Rheum 50 (2004) 927-936
20. Quarck R., Nawrot T., Meyns B., et al. C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension. J Am Coll Cardiol 53 (2009) 1211-1218